NAS:NVUS (USA) Also Trade In: Germany

Novus Therapeutics Inc $ 24.41 0.31 (1.29%)

Volume:
23,383
Avg Vol (1m):
33,059
Market Cap $:
35.06 Mil
Enterprise Value $:
-79,223,000.00
P/E (TTM):
0.00
P/B:
1.40
Warning! GuruFocus has detected 1 Severe warning sign with NVUS. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

Novus Therapeutics Inc News and Headlines -

GuruFocus Articles Total 1
  • 1

2014 has been an eventful year on Wall Street. Now that the year is coming to an end, what stocks should investors be on the lookout for in the first quarter of the New Year? To answer this question, William Blair analyst Y. Katherine Xu named 5 Biotechnology stocks to watch in the first quarter of 2015.

Medivation:

Medivation (NASDAQ: MDVN) is best known for developing therapies to treat serious diseases. Earlier this year, the biopharmaceutical company received FDA approval to expand the use of Xtandi, a prescription medicine used to treat men with prostate cancer. Since the

1436 Views    TipRanks    2014-12-23 19:47